Clinical Trials

1 studies in chondrosarcoma

1. Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma Rochester, MN View Summary
   Close

   Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

   Location:

   Rochester, MN

   Trial status:

   Open for Enrollment

   Why is this study being done?

   The purpose of this study is to determine the effectiveness and safety of single agent pazopanib in subjects with chondrosarcoma.

   NCT ID:

   NCT01330966

   • Print Summary
   • View study details

   Who can I contact for additional information about this study?

   Rochester: 507-538-7623
                       
   
   
   

   Request Information Online